financetom
Business
financetom
/
Business
/
Economy picking up; order situation improving, says Thermax's Ashish Bhandari
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Economy picking up; order situation improving, says Thermax's Ashish Bhandari
Mar 9, 2021 3:41 AM

Winning orders has been challenging in such an environment for Thermax. Ashish Bhandari, MD and CEO of Thermax, discussed if there has been any improvement in Q4 and where are they witnessing conversion of inquiries the most.

Share Market Live

NSE

"Over the last three quarters, after the pandemic started, in each quarter our performance has improved. In the last quarter, December, the numbers were almost in-line with where we were a year ago,” he said.

"The next three months, as the weather is starting to get hotter, looks like the economy is also picking up and across the board our order situation continues to get better there as well,” he added.

The company is focused on multi-sectors. "We continue to get demand across industries which is something that we are seeing in textile, cement, steel, oil and gas and food sectors. Across multiple sectors, we are seeing a fair pick up in orders, in inquiries and execution starts to get better on the ground,” he said.

When the company started the recovery, the initial set of orders were from food, pharmaceuticals and chemicals.

“It is truly a broad-based recovery across all segments. Across the economy, the recovery is decent. The situation is certainly much better than what was anytime over the last 12-15 months,” he stated.

In terms of capacity utilisation, he said, “The capacity utilisation changes also from the various sub-segments that we have. In specialty chemicals segment, we have just increased capacity and we are ramping it up hoping to fill that capacity. In boiler segment, our capacities are going up. We are looking at what we can do to increase capacity.”

For full interview, watch the video.

(Edited by : Priyanka Rathi)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boot Barn Holdings Fiscal Q4 Net Income, Sales Fall; Fiscal Q1, 2025 Outlook Set; Shares Slump After Hours
Boot Barn Holdings Fiscal Q4 Net Income, Sales Fall; Fiscal Q1, 2025 Outlook Set; Shares Slump After Hours
May 14, 2024
04:28 PM EDT, 05/14/2024 (MT Newswires) -- Boot Barn Holdings ( BOOT ) reported fiscal Q4 net income Tuesday of $0.96 per diluted share, down from $1.53 a year earlier. Analysts polled by Capital IQ expected EPS of $0.89. Net sales in the quarter ended March 30 fell to $388.5 million from $425.7 million a year earlier. Analysts surveyed by...
Lennar Insider Sold Shares Worth $1,627,000, According to a Recent SEC Filing
Lennar Insider Sold Shares Worth $1,627,000, According to a Recent SEC Filing
May 14, 2024
04:27 PM EDT, 05/14/2024 (MT Newswires) -- Jeffrey Joseph McCall, Executive Vice President, on May 10, 2024, sold 10,000 shares in Lennar ( LEN ) for $1,627,000. Following the Form 4 filing with the SEC, McCall has control over a total of 131,512 shares of the company, with 131,512 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/920760/000095017024059589/xslF345X03/ownership.xml Price: 162.33, Change: +0.10, Percent...
Canoo Q1 Results: EV Manufacturer Misses Earnings Estimates
Canoo Q1 Results: EV Manufacturer Misses Earnings Estimates
May 14, 2024
Canoo Inc. ( GOEV ) reported first-quarter financial results after the bell Tuesday. Here's a look at the details.  The Details: Canoo ( GOEV ) reported quarterly losses of $1.13 per share, which missed the analyst consensus estimate of losses of 97 cents by 16.49%. The company reported zero in quarterly sales, in line with estimates. Net cash used in...
Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing
Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing
May 14, 2024
04:27 PM EDT, 05/14/2024 (MT Newswires) -- Jessica Hopfield, Director, on May 13, 2024, executed a purchase for 45,000 shares in Editas Medicine ( EDIT ) for $253,868. Following the Form 4 filing with the SEC, Hopfield has control over a total of 67,700 shares of the company, with 67,700 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000039/xslF345X03/wk-form4_1715717825.xml Price: 5.89, Change: +0.21,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved